ROCK HILL, S.C., Sept. 26, 2019 /PRNewswire/ — 3D Systems (NYSE: DDD) announced that the Food and Drug Administration (FDA) has provided 510(k) clearance to its  new VSP Orthopaedics solution — enabling surgeons to obtain a clear 3D visualization of a patient’s anatomy and develop a personalized surgical plan, prior to entering the operating room.  The expansion of 3D Systems’ …